Efficacy and safety of low-dose IL-2 as an add-on therapy to riluzole (MIROCALS): a phase 2b, double-blind, randomised, placebo-controlled trialGilbert Bensimon, Massimo Locati, Christine Payan et al.|The Lancet|2025Cited by 33
Development and Validation of an Acute Respiratory Distress Syndrome Prediction Model in Coronavirus Disease 2019Aysun Tekin, Yewande Odeyemi, Shahraz Qamar et al.|Mayo Clinic Proceedings|2022Cited by 1